InfuSystems Current Deferred Revenue vs Cost Of Revenue Analysis

INFU Stock

USD 8.90 0.04 0.45%

InfuSystems Holdings financial indicator trend analysis is infinitely more than just investigating InfuSystems Holdings recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether InfuSystems Holdings is a good investment. Please check the relationship between InfuSystems Holdings Current Deferred Revenue and its Cost Of Revenue accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InfuSystems Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

For more information on how to buy InfuSystems Stock please use our How to Invest in InfuSystems Holdings guide.

Current Deferred Revenue vs Cost Of Revenue

Current Deferred Revenue vs Cost Of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of InfuSystems Holdings Current Deferred Revenue account and Cost Of Revenue. At this time, the significance of the direction appears to have weak relationship.

The correlation between InfuSystems Holdings' Current Deferred Revenue and Cost Of Revenue is 0.31. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of InfuSystems Holdings, assuming nothing else is changed. The correlation between historical values of InfuSystems Holdings' Current Deferred Revenue and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of InfuSystems Holdings are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Current Deferred Revenue i.e., InfuSystems Holdings' Current Deferred Revenue and Cost Of Revenue go up and down completely randomly.

Correlation Coefficient

0.31

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Cost Of Revenue

Cost of Revenue is found on InfuSystems Holdings income statement and represents the costs associated with goods and services InfuSystems Holdings provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most indicators from InfuSystems Holdings' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into InfuSystems Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InfuSystems Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

For more information on how to buy InfuSystems Stock please use our How to Invest in InfuSystems Holdings guide.At this time, InfuSystems Holdings' Sales General And Administrative To Revenue is comparatively stable compared to the past year. Enterprise Value Over EBITDA is likely to gain to 16.41 in 2024, whereas Selling General Administrative is likely to drop slightly above 43.1 M in 2024.

	2021	2022	2023	2024 (projected)
Other Operating Expenses	99.6M	108.3M	121.7M	65.7M
Interest Expense	1.4M	1.4M	2.2M	1.6M

Other Operating Expenses Interest Expense

InfuSystems Holdings fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Accounts Payable	Other Assets	Non Current Liabilities Total	Other Current Assets	Property Plant And Equipment Net	Net Receivables	Good Will	Inventory
Total Assets		0.88	0.75	0.76	0.89	0.9	-0.69	0.11	0.96	0.03	0.11	0.9	0.88	0.73	0.88	0.86	0.22	0.9	0.72	0.88	0.64	0.41	0.36	0.72	-0.79	0.62
Short Long Term Debt Total	0.88		0.81	0.9	0.6	0.97	-0.79	0.39	0.84	-0.03	0.39	0.86	0.83	0.71	0.99	0.86	0.41	0.86	0.8	0.84	0.76	0.32	0.53	0.62	-0.76	0.5
Other Current Liab	0.75	0.81		0.75	0.51	0.8	-0.63	0.33	0.67	-0.05	0.33	0.65	0.57	0.37	0.86	0.89	0.14	0.65	0.76	0.67	0.81	0.53	0.54	0.81	-0.83	0.59
Total Current Liabilities	0.76	0.9	0.75		0.47	0.83	-0.65	0.54	0.7	0.11	0.54	0.75	0.74	0.55	0.9	0.79	0.64	0.75	0.75	0.79	0.57	0.24	0.49	0.51	-0.63	0.39
Total Stockholder Equity	0.89	0.6	0.51	0.47		0.68	-0.43	-0.09	0.93	-0.04	-0.09	0.76	0.77	0.62	0.6	0.69	0.13	0.76	0.48	0.77	0.35	0.2	0.18	0.62	-0.53	0.42
Net Debt	0.9	0.97	0.8	0.83	0.68		-0.8	0.18	0.89	-0.11	0.18	0.87	0.84	0.72	0.97	0.84	0.3	0.87	0.84	0.79	0.77	0.31	0.53	0.67	-0.77	0.52
Retained Earnings	-0.69	-0.79	-0.63	-0.65	-0.43	-0.8		-0.13	-0.64	-0.02	-0.13	-0.87	-0.83	-0.78	-0.8	-0.65	-0.11	-0.87	-0.74	-0.69	-0.55	-0.32	-0.26	-0.47	0.8	-0.52
Cash	0.11	0.39	0.33	0.54	-0.09	0.18	-0.13		0.07	0.01	1.0	0.16	0.2	0.16	0.36	0.37	0.66	0.16	0.15	0.4	0.16	-0.14	0.34	0.01	-0.07	-0.2
Non Current Assets Total	0.96	0.84	0.67	0.7	0.93	0.89	-0.64	0.07		-0.13	0.07	0.88	0.89	0.72	0.83	0.79	0.3	0.88	0.67	0.87	0.54	0.18	0.4	0.63	-0.65	0.43
Non Currrent Assets Other	0.03	-0.03	-0.05	0.11	-0.04	-0.11	-0.02	0.01	-0.13		0.01	0.15	0.02	0.03	-0.04	0.03	0.08	0.15	-0.18	0.04	-0.17	0.31	-0.73	-0.02	-0.01	0.3
Cash And Short Term Investments	0.11	0.39	0.33	0.54	-0.09	0.18	-0.13	1.0	0.07	0.01		0.16	0.2	0.16	0.36	0.37	0.66	0.16	0.15	0.4	0.16	-0.14	0.34	0.01	-0.07	-0.2
Common Stock Total Equity	0.9	0.86	0.65	0.75	0.76	0.87	-0.87	0.16	0.88	0.15	0.16		0.97	0.83	0.85	0.77	0.31	1.0	0.68	0.91	0.46	0.25	0.17	0.53	-0.75	0.5
Common Stock Shares Outstanding	0.88	0.83	0.57	0.74	0.77	0.84	-0.83	0.2	0.89	0.02	0.2	0.97		0.87	0.81	0.7	0.38	0.97	0.64	0.92	0.38	0.08	0.25	0.45	-0.65	0.34
Other Stockholder Equity	0.73	0.71	0.37	0.55	0.62	0.72	-0.78	0.16	0.72	0.03	0.16	0.83	0.87		0.69	0.63	0.2	0.83	0.63	0.67	0.4	0.09	0.2	0.45	-0.51	0.32
Total Liab	0.88	0.99	0.86	0.9	0.6	0.97	-0.8	0.36	0.83	-0.04	0.36	0.85	0.81	0.69		0.89	0.34	0.85	0.86	0.81	0.8	0.4	0.57	0.7	-0.82	0.56
Total Current Assets	0.86	0.86	0.89	0.79	0.69	0.84	-0.65	0.37	0.79	0.03	0.37	0.77	0.7	0.63	0.89		0.2	0.77	0.83	0.76	0.76	0.49	0.47	0.88	-0.8	0.6
Short Term Debt	0.22	0.41	0.14	0.64	0.13	0.3	-0.11	0.66	0.3	0.08	0.66	0.31	0.38	0.2	0.34	0.2		0.31	0.1	0.48	-0.12	-0.45	0.2	-0.19	0.13	-0.33
Common Stock	0.9	0.86	0.65	0.75	0.76	0.87	-0.87	0.16	0.88	0.15	0.16	1.0	0.97	0.83	0.85	0.77	0.31		0.68	0.91	0.47	0.25	0.17	0.53	-0.75	0.5
Accounts Payable	0.72	0.8	0.76	0.75	0.48	0.84	-0.74	0.15	0.67	-0.18	0.15	0.68	0.64	0.63	0.86	0.83	0.1	0.68		0.55	0.77	0.44	0.64	0.81	-0.78	0.57
Other Assets	0.88	0.84	0.67	0.79	0.77	0.79	-0.69	0.4	0.87	0.04	0.4	0.91	0.92	0.67	0.81	0.76	0.48	0.91	0.55		0.4	0.16	0.27	0.45	-0.67	0.36
Non Current Liabilities Total	0.64	0.76	0.81	0.57	0.35	0.77	-0.55	0.16	0.54	-0.17	0.16	0.46	0.38	0.4	0.8	0.76	-0.12	0.47	0.77	0.4		0.64	0.63	0.79	-0.77	0.66
Other Current Assets	0.41	0.32	0.53	0.24	0.2	0.31	-0.32	-0.14	0.18	0.31	-0.14	0.25	0.08	0.09	0.4	0.49	-0.45	0.25	0.44	0.16	0.64		0.04	0.63	-0.72	0.95
Property Plant And Equipment Net	0.36	0.53	0.54	0.49	0.18	0.53	-0.26	0.34	0.4	-0.73	0.34	0.17	0.25	0.2	0.57	0.47	0.2	0.17	0.64	0.27	0.63	0.04		0.44	-0.37	0.06
Net Receivables	0.72	0.62	0.81	0.51	0.62	0.67	-0.47	0.01	0.63	-0.02	0.01	0.53	0.45	0.45	0.7	0.88	-0.19	0.53	0.81	0.45	0.79	0.63	0.44		-0.75	0.67
Good Will	-0.79	-0.76	-0.83	-0.63	-0.53	-0.77	0.8	-0.07	-0.65	-0.01	-0.07	-0.75	-0.65	-0.51	-0.82	-0.8	0.13	-0.75	-0.78	-0.67	-0.77	-0.72	-0.37	-0.75		-0.82
Inventory	0.62	0.5	0.59	0.39	0.42	0.52	-0.52	-0.2	0.43	0.3	-0.2	0.5	0.34	0.32	0.56	0.6	-0.33	0.5	0.57	0.36	0.66	0.95	0.06	0.67	-0.82

Click cells to compare fundamentals

InfuSystems Holdings Account Relationship Matchups

InfuSystems Holdings fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	79.2M	97.0M	97.6M	99.4M	102.9M	97.9M
Short Long Term Debt Total	43.0M	42.7M	36.8M	36.9M	36.4M	34.4M
Other Current Liab	5.8M	6.8M	4.7M	6.1M	6.2M	3.9M
Total Current Liabilities	21.8M	23.0M	12.9M	14.5M	15.7M	15.5M
Total Stockholder Equity	22.3M	40.8M	48.3M	48.0M	52.3M	38.5M
Net Debt	40.4M	33.0M	36.6M	36.8M	36.1M	29.2M
Retained Earnings	(61.4M)	(44.0M)	(53.9M)	(59.3M)	(58.6M)	(55.7M)
Cash	2.6M	9.6M	186K	165K	231K	219.5K
Non Current Assets Total	59.9M	67.2M	75.5M	74.6M	72.3M	57.6M
Non Currrent Assets Other	1.5M	1.7M	(39.8M)	(39.4M)	41M	43.1M
Cash And Short Term Investments	2.6M	9.6M	186K	165K	231K	219.5K
Common Stock Shares Outstanding	20.8M	21.7M	22.0M	21.5M	21.6M	21.8M
Liabilities And Stockholders Equity	79.2M	97.0M	97.6M	99.4M	102.9M	97.9M
Other Stockholder Equity	83.7M	84.8M	101.9M	105.9M	109.8M	102.4M
Total Liab	56.9M	56.2M	49.3M	51.4M	50.6M	45.0M
Total Current Assets	19.3M	29.8M	22.1M	24.8M	30.6M	17.7M
Accumulated Other Comprehensive Income	(42.0M)	(44.6M)	268K	1.5M	1.1M	1.1M
Short Term Debt	8.1M	9.4M	349K	931K	1.5M	1.4M
Accounts Payable	8.0M	6.8M	7.9M	8.3M	8.0M	5.2M
Other Assets	1.5M	51.7M	12.2M	12.5M	14.4M	15.1M
Non Current Liabilities Total	35.0M	33.2M	36.4M	36.9M	34.9M	31.1M
Other Current Assets	1.7M	2.4M	2.5M	2.9M	4.2M	4.4M
Property Plant And Equipment Net	43.0M	44.4M	48.6M	48.0M	11.0M	10.5M
Net Receivables	12.1M	14.7M	15.4M	16.9M	19.8M	12.0M
Good Will	19.9M	15.5M	11.2M	3.7M	3.3M	3.2M
Inventory	2.9M	3.0M	3.9M	4.8M	6.4M	6.7M
Property Plant And Equipment Gross	43.0M	4.3M	4.5M	4.4M	111.1M	116.7M
Intangible Assets	15.5M	11.2M	10.9M	8.4M	7.4M	7.1M
Long Term Debt	30.3M	29.4M	32.7M	33.2M	29.1M	29.1M
Property Plant Equipment	4.0M	44.4M	48.6M	2.8M	3.2M	3.0M
Net Tangible Assets	22.3M	29.6M	33.6M	44.3M	50.9M	53.5M
Retained Earnings Total Equity	(61.4M)	(44.0M)	(53.9M)	(59.3M)	(53.4M)	(56.1M)
Capital Surpluse	83.7M	84.8M	101.9M	105.9M	121.7M	100.3M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for InfuSystems Stock Analysis

When running InfuSystems Holdings' price analysis, check to measure InfuSystems Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InfuSystems Holdings is operating at the current time. Most of InfuSystems Holdings' value examination focuses on studying past and present price action to predict the probability of InfuSystems Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InfuSystems Holdings' price. Additionally, you may evaluate how the addition of InfuSystems Holdings to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC